Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Colgate Palmolive |
---|---|
Information provided by: | Colgate Palmolive |
ClinicalTrials.gov Identifier: | NCT00759187 |
The purpose of this study is to conduct a clinical study comparing anti-plaque efficacy of commercial oral care products.
Condition | Intervention | Phase |
---|---|---|
Gingival Diseases |
Drug: Fluoride Drug: Triclosan/Fluoride Drug: Chlorhexidine Gluconate |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Evaluate Clinical Research From Commerical Oral Care Products |
Enrollment: | 25 |
Study Start Date: | January 2008 |
Study Completion Date: | April 2008 |
Primary Completion Date: | April 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
A: Placebo Comparator |
Drug: Fluoride
Brush twice daily
|
B: Active Comparator |
Drug: Triclosan/Fluoride
Half mouth toothbrushing twice daily for 4 days
|
C: Active Comparator |
Drug: Chlorhexidine Gluconate
Mouth rinsing twice a day for 4 days
|
The purpose of this study is to compare efficacy of two commercially available toothpastes and one oral rinse on dental plaque control.
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, Massachusetts | |
Boston University School of Dental Medicine | |
Boston, Massachusetts, United States, 02118 |
Principal Investigator: | Thomas Van Dyke, DDS | Unaffiliated |
Responsible Party: | Colgate Palmolive ( William DeVizio/VP - Clinical Research ) |
Study ID Numbers: | CRO-0607-PLA-11-RR |
Study First Received: | September 23, 2008 |
Results First Received: | October 16, 2008 |
Last Updated: | November 11, 2008 |
ClinicalTrials.gov Identifier: | NCT00759187 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Antimetabolites Mouth Diseases Anti-Infective Agents Gingival Diseases Chlorhexidine Antilipemic Agents Anti-Infective Agents, Local |
Periodontal Diseases Disinfectants Chlorhexidine gluconate Hexachlorophene Stomatognathic Diseases Fluorides Triclosan |
Antimetabolites Mouth Diseases Anti-Infective Agents Gingival Diseases Chlorhexidine Molecular Mechanisms of Pharmacological Action Antilipemic Agents Physiological Effects of Drugs Protective Agents Pharmacologic Actions Anti-Infective Agents, Local |
Disinfectants Periodontal Diseases Cariostatic Agents Chlorhexidine gluconate Hexachlorophene Therapeutic Uses Stomatognathic Diseases Fluorides Dermatologic Agents Triclosan Fatty Acid Synthesis Inhibitors |